---
title: PSI vs Novotech
slug_a: appian
slug_b: novotech-cro
site: cro
review_signal_gate: closed
canonical_path: /compare/appian/novotech-cro
---

# PSI vs Novotech

Side-by-side profile data from each company listing on this directory.

## PSI

- Profile: [/companies/appian](/companies/appian)

PSI — PSI runs full-service Phase 2 and 3 clinical trials with a stated focus on on-time enrollment and over 90% repeat and referral business. Key therapeutic areas include oncology, GI, hematology, cell and gene therapy, neurology, and infectious diseases.

Services: 3. Modalities: 3. Indications: 9. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in indications (9).

### Services

- Phase II Clinical Trials
- Phase III Clinical Trials
- Clinical Operations

### Modalities

- Cell Therapy
- Gene Therapy
- Radiopharmaceutical

### Indications

- Oncology
- Immunology
- Neurology
- Metabolic
- Cardiovascular
- Infectious Disease
- Respiratory
- Gastroenterology
- Nephrology

### Phases

- Phase II
- Phase III

### Sourcing models

- Full-Service Outsourcing (FSO)

## Novotech

- Profile: [/companies/novotech-cro](/companies/novotech-cro)

Novotech — Global full-service CRO specializing in early-phase and oncology trials across 50+ countries, with expertise in cardiovascular, cell and gene therapy, and radiopharmaceutical development.

Services: 19. Modalities: 5. Indications: 3. Locations: 2. Certifications: 0. The strongest documented coverage currently appears in services (19).

### Services

- Bioanalysis
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Central Laboratory Services
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy
- Immunology & Inflammation Services
- Oncology Specialty Services
- Cardiovascular & Metabolic Specialty Services

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Radiopharmaceutical

### Indications

- Oncology
- Immunology
- Cardiovascular

### Phases

- Phase I
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)